Galmed pharmaceuticals ltd. reports earnings results for the third quarter ended september 30, 2019

Galmed pharmaceuticals ltd. announced earnings results for the third quarter ended september 30, 2019. for the third quarter, the company announced sales was usd 0 compared to usd 1.500 million a year ago. operating loss was usd 5.007 million compared to usd 1.180 million a year ago. net loss was usd 4.514 million compared to usd 959,000 a year ago. basic loss per share was usd 0.21 compared to usd 0.05 a year ago. for the nine months, sales was usd 0 compared to usd 2.038 million a year ago. operating loss was usd 13.748 million compared to usd 6.514 million a year ago. net loss was usd 12.175 million compared to usd 6.150 million a year ago. basic loss per share was usd 0.58 compared to usd 0.36 a year ago.
GLMD Ratings Summary
GLMD Quant Ranking